An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Agen, France, 47000
- Clinique Du Docteur Calabet; Cromg
-
Aix En Provence, France, 13617
- Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire
-
Aix En Provence, France, 13616
- C H Du Pays D'Aix En Provence; Hopital De Jour
-
Aix En Provence, France, 13616
- Ch Du Pays D Aix; Maternite Gynecologie
-
Albi, France, 81030
- Clinique Claude Bernard; Onco Hematologie
-
Albi, France, 81000
- Centre Hospitalier Albi; Oncologie
-
Antony, France, 92166
- Hopital Prive D Antony; Oncologie
-
Aurillac, France, 15013
- Cmc De Tronquieres;Chimiotherapie Et Radiotherapie
-
Auxerre, France, 89011
- Ch D Auxerre; Oncologie
-
Bastia, France, 20200
- Clinique Du Docteur Maymard; Hopital De Jour Chimiotherapie
-
Bastia, France, 20604
- Hopital De Falconaja Furiani; Hopital De Jour
-
Bayonne, France, 64100
- Centre Oncologie Du Pays Basque
-
Besancon, France, 25030
- HOPITAL JEAN MINJOZ; Oncologie
-
Beuvry, France, 62660
- Centre Pierre Curie
-
Beziers, France, 34525
- Ch De Beziers; Hematologie
-
Bobigny, France, 93009
- Hopital Avicenne; Cancerologie
-
Bordeaux, France, 33030
- Clinique Tivoli; Chimiotherapie Radiotherapie
-
Bordeaux, France, 33077
- Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie
-
Bourg En Bresse, France, 01012
- Centre Hospitalier Fleyriat; Oncologie/Hematologie
-
Brest, France, 29200
- Hopital Augustin Morvan; Federation De Cancerologie
-
Brest, France, 29220
- Clinique Pasteur Lanroze; Chimiotherapie Radiotherapie
-
Briis Sous Forges, France, 91640
- CMC de Bligny; Oncologie Court Sejour
-
Cannes, France, 06400
- Hopital Pierre Nouveau; Medecine A
-
Carcassonne, France
- Clinique Montreal; Chimiotherapie
-
Carcassonne, France, 11000
- CH Carcassonne; Service Onco Hematologie
-
Challes Les Eaux, France, 73190
- Medipole De Savoie; Departement Oncologie
-
Champigny Sur Marne, France, 94507
- Hopital Prive Paul d Egine; Chimiotherapie Ambulatoire
-
Cholet, France, 49325
- CH de Cholet; oncologie
-
Clamart Cedex, France, 92141
- Hopital Antoine Beclere; Hopital De Jour
-
Compiegne, France, 60200
- Centre De Radiotherapie Et D'Oncologie; Oncologie
-
Creil Cedex 1, France, 60109
- Groupe Hospitalier Public Du Sud De L'Oise GHPSO; Oncologie
-
Creteil, France, 94010
- Chi De Creteil; Radiotherapie Oncologie
-
Creteil, France, 94010
- Hopital Henri Mondor; Oncologie Medicale
-
Dechy, France, 59187
- Centre Leonard De Vinci;Chimiotherapie
-
Dijon, France, 21000
- Centre de Radiotherapie du Parc
-
Draguignan, France, 83007
- Ch De La Dracenie; Hopital De Jour
-
Epinal, France, 88021
- Chi Emile Durkheim Site Epinal; Oncologie
-
Ermont, France, 95120
- Clinique Claude Bernard; Chimiotherapie
-
Frejus, France, 83608
- Chi De Frejus Saint Raphael; Oncologie
-
GAP, France, 05000
- Chi Alpes Du Sud Site De Gap; Med Interne Et Polyvalente
-
Guilherand Granges, France, 07500
- Centre Mistral; Chirurgie Cancerologie Gynecologiques
-
Jossigny, France, 77600
- CH de Marne la vallee; Oncologie Medicale
-
La Tronche, France, 38700
- Hopital Albert Michallon; Oncologie
-
Le Coudray, France, 28630
- Hopital Louis Pasteur; Oncologie Hematologie
-
Le Mans, France, 72037
- Ch Du Mans; Medecine Hematologie Oncologie
-
Lille, France, 59003
- Polyclinique Du Bois; Oncologie
-
Limoges, France, 87039
- Clinique Chenieux; Oncology
-
Longjumeau, France, 91161
- Ch De Longjumeau; Hopital De Jour Et Semaine
-
Lons Le Saunier, France, 39016
- Ch De Lons Le Saunier; Medecine 5
-
Lorient, France, 56100
- Ch Bretagne Sud Site Scorff; Oncologie Medicale
-
Lyon, France, 69337
- Clinique De La Sauvegarde; Chimiotherapie
-
Mareuil Les Meaux, France, 77100
- Clinique Saint Faron; Sce Oncologie Radiotherapie
-
Marseille, France, 13004
- Ctre Hosp Prive Beauregard; Hop De Jour Chimiotherapie
-
Metz, France, 57000
- Hopital Clinique Claude Bernard; Oncologie Medicale
-
Mont-de-marsan, France, 40024
- Hopital Layne; Medecine Ambulatoire
-
Montfermeil, France, 93370
- Ghi Le Raincy Montfermeil; Oncologie Medicale
-
Montlucon, France, 03100
- Ch De Montlucon; Hematologie Cancerologie
-
Montpellier, France, 34070
- Clinique Clementville; Hopital De Jour
-
Nancy, France, 54100
- Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE
-
Nantes, France, 44202
- Centre Catherine de Sienne; Chimiotherapie
-
Narbonne, France, 11780
- Polyclinique Du Languedoc; Chimiotherapie
-
Nimes, France, 30029
- Hopital Caremeau; Hematologie Oncologie
-
Nimes, France, 30900
- Clinique Valdegour
-
Nimes Cedex 9, France, 30029
- Hopital Caremeau; Maternite Gynecologie
-
Niort, France, 79021
- Ch Georges Renon; Oncologie Radiotherapie
-
Osny, France, 95520
- CROM
-
Paris, France, 75674
- GH Paris Saint Joseph; Hopital De Jour Oncologie
-
Paris, France, 75651
- Ch Pitie Salpetriere; Oncologie Medicale
-
Pau, France, 64046
- Ch Francois Mitterrand; Medecine Oncologie
-
Perigueux, France, 24000
- Polyclinique Francheville; MED CHIMIOTHERAPIE RADIOTHERAPIE
-
Perpignan, France, 66000
- Centre Catalan D' Oncologie
-
Perpignan, France, 66046
- Hopital Saint Jean; Centre Henri Pujol
-
Pontoise, France, 95300
- CH Rene Dubos; Oncologie
-
Pringy, France, 74374
- CH Annecy Genevois site Annecy; Oncologie
-
Quimper, France, 29107
- Chi De Cornouaille; Oncologie Hospitalisation
-
Reims, France, 51056
- Institut Jean Godinot; Pavillon Rubis
-
Ris Orangis, France, 91130
- Clinique de la Theuillerie; Oncologie
-
Saint Brieuc, France, 22015
- Clinique Armoricaine Radiologie; Cons Externes
-
Saint Dizier, France, 52100
- Clinique Francois 1er; Service De Chimiotherapie
-
Saint Gregoire, France, 35768
- Chp Saint Gregoire; Cancerologie Radiotherapie
-
Saint Jean, France, 31240
- Clinique de L'Union; Oncologie
-
Saint Nazaire, France, 44606
- Clinique Mutualiste L Estuaire
-
Sens, France, 89108
- Ch Gaston Ramon; Hopital De Jour
-
Sens Cedex, France, 89108
- Centre Hospitalier De Sens; Medecine Generale Oncologie
-
Soyaux, France, 16800
- Centre Clinical; Oncologie Medicale
-
St Jean De Maurienne Cedex, France, 73303
- CH de Saint Jean De Maurienne; Had St Jean De Maurienne
-
Stains, France, 93240
- Clinique De L Estree; Oncologie Medicale
-
Ste Foy Les Lyon, France, 69110
- Clinique Medico Chir Charcot; Chir Cancerologie
-
Strasbourg, France, 67000
- Strasbourg Oncologie Libérale
-
Strasbourg, France, 67000
- Institut D Oncologie Medical
-
Strasbourg, France, 67091
- Hopital Civil; Hematologie Oncologie
-
Thonon Les Bains, France, 74203
- Hopitaux Du Leman Site Thonon; Maternite Gynecologie
-
Toulouse, France, 31076
- Clinique Pasteur; Oncologie Medicale
-
Toulouse, France, 31077
- Clinique Saint Jean Languedoc; Oncologie Medicale
-
Tours, France, 37044
- Hopital Bretonneau; Clinique D'Oncologie & de Radiotherapie
-
Vandoeuvre Les Nancy, France, 54511
- Centre Alexis Vautrin; Oncologie Medicale
-
Villeneuve D Ascq, France, 59657
- Hopital Prive Villeneuve d Ascq;Chimiotherapie Radiotherapie
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged >/= 18 years
- Patients with HER2-positive early breast cancer who according to national guidelines are eligible for neoadjuvant or adjuvant HER2+ treatment
- Patients for whom the investigator has decided to start a treatment with Herceptin SC
- Trastuzumab treatment naive or non-naive (previously intravenous treatment)
- Informed consent
Exclusion Criteria:
- Patients previously treated with Herceptin SC treatment
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Cohort
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety (composite outcome measure): Incidence, nature, and severity according to NCI-CTCAE v. 4.0 of: adverse events (AEs), serious AEs, grade >/= 3 AEs, non-serious adverse drug reaction or causality unknown, AESI (congestive heart failure)
Time Frame: approximately 13 months
|
approximately 13 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Demographic data
Time Frame: Up to 12 months
|
Up to 12 months
|
|
Number of modalities regarding dose and injection site of Herceptin SC administration
Time Frame: Up to 12 months
|
Up to 12 months
|
|
Patient-reported outcome: Quality of Life using the EORTC QLQ-C30 questionnaire
Time Frame: Every 3 months, up to 12 months
|
Every 3 months, up to 12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ML28983
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.